MedPath

ASSESSMENT OF TREATMENT AFTER PERFORMING THERAPY ON IMMATURE PERMANENT TEETH WITH DENTAL MATERIALS THAT HAVE A STIMULATORY EFFECT ON PULP.

Not Applicable
Conditions
Health Condition 1: K029- Dental caries, unspecified
Registration Number
CTRI/2021/04/032634
Lead Sponsor
Dr Abhinav Talekar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with young permanent teeth having vital pulp.

Patients having permanent molars with a deep carious lesion.

Patients with pulp exposure due to caries or trauma.

Patients with carious teeth having spontaneous pain.

Patients with no h/o swelling.

Patients with no clinical or radiographic evidence of pulp degeneration.

Patients willing to participate in the study

Exclusion Criteria

Patients with such excessive bleeding from the root canal, indicating irreversible pulpitis.

Patients with teeth showing radiographic evidence internal or external root resorption.

Patients with radiographic evidence of periapical lesion.

Patients with clinical presence of swelling or sinus tract

Patients unwilling to participate in the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
There is a significant difference in clinical performance of Neoputty, Neomta and Biodentine used in vital pulp therapy of young permanent teeth.Timepoint: 2 Weeks, 3 Months , 6 Months , 12 Months
Secondary Outcome Measures
NameTimeMethod
There is a no significant difference in clinical performance of Neoputty, Neomta and Biodentine used in vital pulp therapy of young permanent teethTimepoint: 2 wWeeks <br/ ><br>3 Months <br/ ><br>6 Months <br/ ><br>12 Months
© Copyright 2025. All Rights Reserved by MedPath